In more detail, it was demonstrated that these tumors were characterized by a significant decrease in tumor-supportive MRC1+ cells, an increase in cytotoxic MHCII+ cells, a reduced total number of intratumor Iba1+ myeloid cells, and lower VEGF-A expression. This evidence concerns the gene MRC1 and neoplasm.